NPC2 and hepatocellular carcinoma: Previously, we conducted an immunohistochemical-based study to examine the expression of NPC2 in a variety of different human cancers, and meanwhile NPC2 was found to be down-regulated in human liver cirrhosis and hepatoma tissues [22].